FY2025 · period end Dec '25 · from the 10-K filed Feb 18, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $5.10B | $4.79B | $4.15B | $3.77B | $3.77B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $0.11B | $0.16B | $0.13B | $0.21B | $0.33B |
| Net Income | negative: -$0.36B | negative: -$0.32B | negative: -$0.26B | $0.01B | $0.18B |
| EPS (Diluted) | negative: -$1.02 | negative: -$0.90 | negative: -$0.74 | $0.02 | $0.52 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $14.02B | $13.47B | $13.44B | $11.14B | $10.82B |
| Total Liabilities | $7.50B | $6.92B | $6.52B | $4.04B | $1.42B |
| Stockholders' Equity | $6.52B | $6.54B | $6.92B | $7.10B | $9.40B |
| Cash & Equivalents | $0.38B | $0.30B | $0.33B | $0.35B | $0.17B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.28B | $0.23B | negative: -$0.02B | $0.34B | $0.87B |
| Capital Expenditures | $0.35B | $0.29B | $0.18B | $0.17B | $0.19B |
| Free Cash Flow | negative: -$0.07B | negative: -$0.06B | negative: -$0.20B | $0.17B | $0.68B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | negative: -0.0% | negative: -0.0% | negative: -0.0% | 0.1% | 0.1% |
| Net Margin | negative: -0.1% | negative: -0.1% | negative: -0.1% | 0.0% | 0.0% |
| Return on Equity | negative: -5.5% | negative: -4.7% | negative: -3.7% | 0.1% | 1.9% |
| Return on Assets | negative: -2.6% | negative: -2.4% | negative: -2.1% | 0.1% | 1.7% |
| Debt / Equity | 0.77× | 0.73× | 0.66× | 0.34× | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000950103-26-011979 | Aug 5, 2026 | Aug 6, 2026 | Aug 6, 2026 11:10 UTC | EDGAR |
| 8-K | 0001860742-26-000086 | Jul 29, 2026 | Jul 29, 2026 | Jul 29, 2026 11:02 UTC | EDGAR |
| 10-Q | 0001860742-26-000088 | Jun 30, 2026 | Jul 29, 2026 | Jul 29, 2026 20:17 UTC | EDGAR |
| 8-K | 0001193125-26-232712 | May 20, 2026 | May 20, 2026 | May 20, 2026 20:32 UTC | EDGAR |
| 8-K | 0001860742-26-000060 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 11:01 UTC | EDGAR |
| 10-Q | 0001860742-26-000062 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 20:36 UTC | EDGAR |
| 8-K | 0001860742-26-000006 | Feb 18, 2026 | Feb 18, 2026 | Feb 18, 2026 12:01 UTC | EDGAR |
| 10-K | 0001860742-26-000007 | Dec 31, 2025 | Feb 18, 2026 | Feb 18, 2026 22:19 UTC | EDGAR |
Direct links to SEC EDGAR. BLCO has additional filings available on the SEC site.
6 numbers Bausch & Lomb Corp later changed — same XBRL tag, both filings linked.
Deferred Tax Assets, Valuation Allowance·As of Dec 31, 2021
Major restatementwas$53M
Revised down in a 10-K.
Other Noncash Income (Expense)·FY 2024
Major restatementwas$19M
Revised down in a 10-K.
Unrecognized Tax Benefits·As of Dec 31, 2025
Major restatementwas$59M
Revised up in a 10-Q.
Other Accrued Liabilities, Current·As of Dec 31, 2022
Major restatementwas$408M
Revised down in a 10-K.
Other Accrued Liabilities, Current·As of Dec 31, 2025
Major restatementwas$487M
Revised up in a 10-Q.
Unrecognized Tax Benefits·As of Dec 31, 2022
Major restatementwas$70M
Revised down in a 10-K.
BLCO is not the only one.
See every restatement we've found across the market — or get an alert the next time BLCO revises a number.
Restatements are detected by comparing every vintage of a fact across all of Bausch & Lomb Corp's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows BLCO's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Bausch & Lomb Corp — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on BLCO yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on BLCO and publish the result to your public profile.
Ask about Bausch & Lomb Corp
Continue in Workspace — cited answers on BLCO, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs